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Abstract
Humans parturition involves interaction of hormonal, neurological, mechanical stretch and inflammatory pathways and the
placenta plays a crucial role. The paraoxonases (PONs 1–3) protect against oxidative damage and lipid peroxidation,
modulation of endoplasmic reticulum stress and regulation of apoptosis. Nothing is known about the role of PON2 in the
placenta and labour. Since PON2 plays a role in oxidative stress and inflammation, both features of labour, we hypothesised
that placental PON2 expression would alter during labour. PON2 was examined in placentas obtained from women who
delivered by cesarean section and were not in labour and compared to the equivalent zone of placentas obtained from
women who delivered vaginally following an uncomplicated labour. Samples were obtained from 12 sites within each
placenta: 4 equally spaced apart pieces were sampled from the inner, middle and outer placental regions. PON2 expression
was investigated by Western blotting and real time PCR. Two PON2 forms, one at 62 kDa and one at 43 kDa were found in
all samples. No difference in protein expression of either isoform was found between the three sites in either the labour or
non-labour group. At the middle site there was a highly significant decrease in PON2 expression in the labour group when
compared to the non-labour group for both the 62 kDa form (p= 0.02) and the 43 kDa form (p = 0.006). No spatial
differences were found within placentas at the mRNA level in either labour or non-labour. There was, paradoxically, an
increase in PON2 mRNA in the labour group at the middle site only. This is the first report to describe changes in PON2 in
the placenta in labour. The physiological and pathological significance of these remains to be elucidated but since PON2 is
anti-inflammatory further studies are warranted to understand its role.
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Introduction
Pregnancy is characterized by a complex interplay of inflam-
matory events regulated by both the innate and acquired immune
systems. In humans parturition involves interaction of hormonal,
neurological, mechanical stretch and inflammatory pathways and
the placenta plays a crucial role [1–4]. The paraoxonases (PON)
are multifaceted and pleiotropic enzymes encoded by three highly
conserved genes (PON1, PON2, and PON3) located on chromo-
some 7q21.3–22.1 [5]. They have multifunctional roles and are
involved in various biochemical pathways. These include protec-
tion against oxidative damage and lipid peroxidation, modulation
of endoplasmic reticulum stress, regulation of cell proliferation/
apoptosis contribution to innate immunity and detoxification of
reactive molecules and bioactivation of drugs [5–6]. Phylogenetic
analysis has shown that PON1 and PON3 arose from gene
duplication of the ancestral PON2 gene [5–6]. PON1 and PON3
are circulating proteins associated with high-density lipoproteins
whereas PON2 is expressed in many tissues and is cell associated
[7]. Research in the PON family has increased greatly in the last
few years, particularly in the cardiovascular field [8].
Nothing is known about the role of PON2 in the placenta or
whether it plays a role in labour. However since PON2 plays a role
in oxidative stress and inflammation, both features of labour, we
hypothesised that placental PON2 expression would alter during
labour. Thus the aim of this study was to examine the spatial
expression of PON2 in placentas obtained from women who
delivered by cesarean section and were not in labour and to
compare the expression of each zone with the equivalent zone of
placentas obtained from women who delivered vaginally following
an uncomplicated labour.
Methods
Ethics statement
Human term placentae were collected from pregnant women at
the Southern General Hospital, Glasgow. All ethics protocols were
followed as per Declaration of Helsinki. The study was approved
by the West of Scotland research ethics service Signed patient
consent was obtained prior to delivery. Patients were handed an
information sheet telling them about the study before being
handed the consent sheet. The information and consent sheets
were also approved by the ethics committee. All signed consent
sheets were stored incase of the need for audit.
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Patients studied
Placentae were collected from: (i) women who had uncompli-
cated pregnancies and delivered at term either vaginally (labour
group, n = 6) or by caesarean section (non-labour group, n = 6).
The labour group were all spontaneous labour and were a tight
group (labour time minimum 3 hours maximum 8 hours). All
placentas were free of infection, confirmed by the pathology report
of every placenta. The non-labour group were all definitely
without labour. All were planned Caesarean sections performed
for obstetric reasons: breach presentation (2) previous caesarean
section (2) or maternal request (2). The groups studied had no
underlying maternal conditions such as hypertension, preeclamp-
sia, diabetes or gestational diabetes or any other medical disorders.
There was no fetal pathology such as fetal growth restriction.
Patient demographics were compared with the student t-test.
There was no significant difference in maternal age (non-labour
28.3365.71 versus labour 2662.28 years), placental weight (non-
labour 594.76110.5 versus labour 589.5675 g), birth weight
(non-labour 34436537 versus labour 37196347 g), number of
primigravid (non-labour n = 2 versus labour n = 4) or number of
smokers (n = 0 labour versus n = 2 non-labour).
Placental sampling
For each patient (6 patients per group), placental samples
(,1 cm3) were obtained from three sites by taking measurements
from the cord insertion point: inner third closest to cord insertion
point (inner zone), middle of placenta (middle zone) and outer
third of placenta (outer zone) of placenta. Within each zone four
separate samples were obtained representing the four quadrants as
previously described [9–11]. Placentas had a central cord
insertion. Samples were rinsed and immediately flash frozen in
liquid nitrogen. For this study we had performed a power analysis
using G*Power 3.1 for Macintosh and based the numbers on
previously published work with the same samples [9–11].
Chemicals
All chemicals were purchased from Sigma-Aldrich (U.K.) unless
stated otherwise.
Tissue Homogenizing For Western Blot
Placental samples were recovered from storage at 270uC and
ground to a fine powder in liquid nitrogen using a mortar and
pestle. The frozen powder was then homogenised in the presence
of protease inhibitors as previously described [9–11]. Placenta
homogenates were spun at 5000 g for 10 min at 4uC to remove
debris then supernatants were collected, divided into aliquots and
stored at 270uC. Protein concentrations were determined by
Bradford analysis using bovine serum albumin as a standard.
Western Blotting
Western blotting was performed as described previously [9–11]
with some modifications. A volume containing 50 mg of each
sample was separated by SDS-PAGE electrophoresis on 10%
sodium dodecyl sulfate-polyacrylamide resolving gels. Pre-stained
low range molecular weight markers (BioRad, UK) were loaded
onto each gel. Transfer of proteins to Hybond ECL nitrocellulose
membranes (Amersham Pharmacia Biotech, UK) was performed
at 22V and 200 mA for 30 min. Membranes were blocked in 5%
goat serum (Serotec) in TBSTB buffer (20 mM TRIS pH 7.5,
0.5 M NaCl, 0.4% Tween and 0.25% bovine serum albumin) for
1 h at room temperature (RT). Primary antibodies were pre-
absorbed in 5% human serum in TBSTB at RT during the
blocking process. Membranes were incubated for 1 h at RT with
primary antibody solution. The PON2 (mouse monoclonal
antibody) was obtained from Santa Cruz Biotechonolgy, USA
Figure 1. Western blots showing PON2 expression in inner, middle and outer zones of three individual placentas (non-labour
group). Four quadrants were sampled in each zone. A, B and C show the 62 kDa isoform 1 for the three placentas shown in Figure 1. D, E and F show
the 43 kDa isoform 2 for the 3 placentas also shown in Figure 1.
doi:10.1371/journal.pone.0096754.g001
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(catalogue number sc-373981) and used at concentration of 1:200.
Membranes were washed and then incubated for 1 h at RT with
horseradish peroxidase conjugated goat anti-mouse secondary
antibody (antibody (SantaCruz (sc-2005) diluted 1:1000 in
TBSTB. Membranes were rinsed with TBSTB (265 min) and
once with distilled water. The same samples were exposed to a b-
actin antibody (Sigma) to confirm even protein loading as shown
previously [9–11]. Immunologically reactive proteins were visual-
ised and quantified as described previously [9–11]. A standard
curve was performed for different blot exposures and densitometry
was performed when bands were on the linear part of the loading
graph as described previously [9–11]. For each group of
experiments the same loading control placenta sample was added
to every gel and the densitometry units were normalized to that.
We previously confirmed that this method of analysis gives similar
findings to other quantitative methods of densitometry [9–11].
Quantitative Real Time-Polymerase Chain Reaction (RT-
PCR)
Total RNA was isolated using the RNeasy Midi Kit (Qiagen,
75142). RNA (100 ng) was reverse transcribed into cDNA. Buffers
and primers were obtained from the QuantiTect Kit (Qiagen,
205310) and GoScript reverse transcriptase from Promega
(A501C). PON2 expression was analyzed by RT-PCR using
validated TaqMan Gene Expression assays with StepOnePlus
(Applied Biosystems). b-actin was used as an endogenous control.
A positive control human placenta cDNA (Primer design) was
Figure 2. Graphs show median and interquartile range for PON2 isoforms 1 and 2 for the combined 4 quadrants sampled in the
inner, middle and outer zones of three different placentas (A, B, C non-labour group) shown in Figure 1. Comparison between zones
was performed using Friedman analysis.
doi:10.1371/journal.pone.0096754.g002
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used. The relative target gene levels were calculated by
comparative CT (DDCT).
Statistical analysis
Patients details were compared using the student t-test.
Statistical analysis was performed using Graphpad prism 5 on a
PC. For Western blot analysis and RT-PCR analysis statistical
analysis was performed using the Friedman test for non-
parametric data.
Results
Experiment 1
This experiment was designed to test if there was a spatial
difference in expression of PON2 within individual placentas
obtained from women who were not in labour. Two main bands
were detected in all placenta samples, one at 62 kDa and one at
43 kDa. These are named as isoform 1 62 kDa and isoform
43 kDa throughout. Examples of Western blots showing PON2
(isoform 1, 62 kDa) expression for 3 different placentas (all non-
labour) are shown in Figure 1 (blots A-C). Examples of Western
blots showing PON2 (isoform 2, 43 kDa) expression for the same
three placentas are also shown in Figure 1 (blots D–F). Friedman
test analysis showed there was no difference in expression of either
isoform between the three sites (inner, middle, outer) within
individual placentas. The graphs for blots A–C (isoform 1, 62 kDa)
are shown in Figure 2 (A–C) and the graphs for blots D–F (isoform
2, 43 kDa) are shown in Figure 2 (D–F).
Experiment 2
This experiment was designed to test if there was a spatial
difference in expression of PON2 within individual placentas
obtained from women who were in labour. Two isoforms (62 kDa
and 43 kDa) were also identified in all placenta samples. Examples
of Western blots showing PON2 (isoform 1, 62 kDa) expression for
3 different placentas (labour) are shown in Figure 3 (blots A–C).
Examples of Western blots showing PON2 (isoform 2, 43 kDa)
expression for the same three placentas are also shown in Figure 3
(blots D–F). Friedman test analysis showed there was also no
difference in expression of either isoform between the three sites
(inner, middle, outer). The graphs for blots A–C (isoform 1,
62 kDa) are shown in Figure 4 (A–C) and the graphs for blots
(isoform 2, 43 kDa) are shown in Figure 4 (D–F). In summary for
experiment 1 and 2, there was no spatial difference in expression
of either PON2 isoform within individual placentas both in non-
labour and in labour groups.
Experiment 3
This experiment was designed to test if there was any difference
in PON2 expression between labour and non-labour groups at the
inner, middle or outer areas of placentas. Western blots showing
placental PON2 expression in non-labour and labour at the inner
site are shown in Figure 5 (upper panel 62 kDa isoform 1; lower
panel 43 kDa isoform 2). The graphs and statistical analysis are
shown below the blots. No differences were found. Western blots
showing placental PON2 expression in non-labour and labour at
the middle site are shown in Figure 6 (upper panel 62 kDa isoform
1; lower panel 43 kDa isoform 2). The graphs and statistical
analysis are shown below the blots. There was a highly significant
decrease in PON2 expression in the labour group when compared
to the non-labour group for both the 62 kDa isoform 1, (p = 0.02)
and the 43 kDa isoform 2, (p = 0.006). Western blots showing
placental PON2 expression in non-labour and labour at the outer
placental site are shown in Figure 7 (upper panel 62 kDa isoform
1; lower panel 43 kDa isoform 2). The graphs and statistical
analysis are shown below the blots. No differences were found.
Experiment 4 was designed to test if there were any differences
in PON2 mRNA expression within individual placentas at
different zones in either labour or non-labour. Figure 8 shows
the PON2 RQ values in the inner, middle and outer zones for non
Figure 3. Western blots showing PON2 expression in inner, middle and outer zones of three individual placentas (labour group).
Four quadrants were sampled in each zone. A, B and C show the 62 kDa isoform 1. D, E and F show the 43 kDa isoform 2.
doi:10.1371/journal.pone.0096754.g003
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labour (A) and labour (B). Just as for both PON2 protein isoforms,
no spatial differences were found at the mRNA level in either
labour or non-labour.
The final experiment 5 tested whether there was any difference
between labour and non-labour at the inner, middle our outer sites
at the mRNA level. The results are shown in Figure 9. As for
PON2 protein no differences were found between labour and non-
labour at the inner or outer placental sites. There was,
paradoxically, an increase in PON2 mRNA in the labour group
at the middle site.
Discussion
PON2 and present findings
The PON family form dimers and trimers and can be
glycosylated; this may, in part, explain the range of different
molecular weights reported to date [12]. In the present study two
main bands were detected with the PON2 antibody. The smaller
band of around 43 kDa is the range reported for PON2. The
larger band around 62 kDa has been described in liver lysates;
reported in the PON2 antibody datasheet (http://www.novusbio.
com/PON2-Antibody_NBP1-52005.html). This larger band was
successfully blocked by incubation with the immunizing peptide
showing it is a form of PON2. The reduced placental expression of
PON2 protein expression found in labour in the middle site would
be likely to promote inflammatory processes. Thus it is possible
that a reduction in PON2 protein may help to initiate or promote
labour but this is speculative. Why PON2 mRNA was found to be
increased may seem paradoxical but it may be that the increased
mRNA is a separate response to oxidative stress as a result of
myometrial contractions. The reduction in PON2 protein could
also be due to processes other than reducing mRNA synthesis,
such as increased protein degradation. PONs are glycosylated with
Figure 4. Graphs show median and interquartile range for the 4 quadrants sampled in the inner, middle and outer zones of each of
the three placentas (labour group) shown in Figure 3. Comparison between zones was performed using Friedman analysis.
doi:10.1371/journal.pone.0096754.g004
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Figure 5. Western blots showing PON2 62 kDa isoform 1 (upper panel) and PON2 43 kDa isoform 2 (lower panel) expression in the
inner placental site in non-labour and labour (n=6 in each group). The graphs show the box and whiskers analysis of the blots. Comparison
between zones was performed using Friedman analysis. Graph A, 62 kDa isoform 1; Graph B, 43 kDa isoform 2. NLG non-labour group, LG labour
group.
doi:10.1371/journal.pone.0096754.g005
Figure 6. Western blots showing PON2 62 kDa isoform 1 (upper panel) and PON2 43 kDa isoform 2 (lower panel) expression in the
middle placental site in non-labour and labour (n=6 in each group). The graphs show the box and whiskers analysis of the blots.
Comparison between zones was performed using Friedman analysis. Graph A, 62 kDa isoform 1; Graph B, 43 kDa isoform 2. NLG non-labour group,
LG labour group.
doi:10.1371/journal.pone.0096754.g006
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high-mannose-type sugars, which are important for protein
stability but are not essential for their enzymatic activities [12].
Whether alterations in glycosylation of PON2 could affect PON2
expression in the placenta would require future research.
Link to oxidative stress and ischemia-reperfusion injury
Oxidative stress occurs when the production of reactive oxygen
species overwhelms the intrinsic anti-oxidant defenses. At the
moment it is not clear whether the observed reduction in PNO2
protein expression in the placenta in the labour group is a
consequence of labour itself or, alternatively, contributed to labour
via endocrine, hemodynamic or other processes. Since human
patients have been used it is difficult to separate these effects. It is
known however that contraction of the uterus leads to ischemic-
reperfusion injury that can alter placental protein expression [13].
Furthermore Doppler ultrasound studies have demonstrated an
inverse relationship between uterine artery resistance and the
intensity of uterine contractions during labour [14]. It has been
shown in chronically instrumented pregnant rhesus monkeys that
placental blood flow is almost completely stopped during sustained
myometrial contractions and that this occurs as a result of
compression of the arcuate and spiral arteries [15,16]. The closest
human model to this was performed on patients prior to
Figure 7. Western blots showing PON2 62 kDa isoform 1 (upper panel) and PON2 43 kDa isoform 2 (lower panel) expression in the
outer site in non-labour and labour (n=6 in each group). The graphs show the box and whiskers analysis of the blots. Comparison between
zones was performed using Friedman analysis. Graph A, 62 kDa isoform 1; Graph B, 43 kDa isoform 2. NLG non-labour group, LG labour group.
doi:10.1371/journal.pone.0096754.g007
Figure 8. RQ values for mRNA measurements in inner, middle and outer placental sites within individual placentas. A non-labour and
B labour. Comparison between zones was performed using Friedman analysis.
doi:10.1371/journal.pone.0096754.g008
Paraoxonase Expression 2 in the Placenta
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termination of pregnancy at 17–20 weeks of gestation [17]. During
oxytocin-induced contractions, a 50% reduction in flow into the
intervillous space, as well as a fall in entry sites and volume, was
found compared to when no contractions occurred. This suggests
that intermittent perfusion of the intervillous space would lead to
an ischemic-reperfusion injury of the placenta. Reactive oxygen
species and the oxidant/antioxidant balance can be affected as a
result [17]. In keeping with this labour has been reported to be
associated with placental alterations in several pathways linked to
oxidative stress [18–24] Other studies looking at heat shock
proteins, Mn-SOD, Cu/Zn-SOD and peroxidation of lipids also
show an association between labour and placental oxidative stress
[9–10,13].
The biochemical events associated with labour involve in-
creased interleukin-1b and prostaglandin synthesis [24]. The later
stages of gestation are likely to be associated with more fluctuations
in blood flow as demand by the placenta and fetus is maximal.
COX-2 increases in mouse and rat placental trophoblast with
gestation [25–26]. In vitro studies also suggest that hypoxia-
reoxygenation increases COX-2 which may in turn play a role in
augmentation or even initiation of labour [26]. Furthermore
human placental trophoblast show activation of the NF-kB and
COX-2 during labour. Increase in levels of cleaved caspase-3 and
cleaved caspase-9 confirm evidence of placental apoptosis during
labour [13]. As will be discussed below PON2 expression and
activity can affect these biochemical events.
PONS
The paroxonases were named so because the substrate for
PON1 is paroxon which is the active metabolite of the
organophosphorus insecticide parathion. PON2 and 3 lack this
esterase activity despite the similar nomenclature. PON1, 2 and 3
are lactonases and PON2 has the highest activity of the three
PONs [5,12,27–29]. PON1 is mainly synthesized by the liver. It
associates with high-density lipoprotein (HDL) in the circulation
[30]. PON1 hydrolyses several substrates; these include organo-
phosphate insecticides and nerve gases, lipid hydroperoxides,
lactones and thiolactones [12,31–33]. PON1 is a potent anti-
atherosclerotic enzyme [34–38]. PON1 and PON3 proteins are
present in plasma and reside in the high-density lipoprotein
fraction and protect against oxidative stress by hydrolyzing certain
oxidized lipids in lipoproteins, macrophages, and atherosclerotic
lesions [37–40]. Paraoxonases are important detoxifying and anti-
oxidative enzymes with roles being described in organophosphate
poisoning, diabetes, obesity, cardiovascular diseases, innate
immunity and with atherosclerosis [41–45]
PON2 and cell death
Endoplasmic reticulum (ER) stress activates the unfolded
protein response (UPR) pathway and pro-apoptotic CHOP
protein in the presence of overwhelming ER stress, [46–48].
Mitochondria also play a key role in cell death via production of
excess reactive oxygen species (ROS) [49]. It has been shown that
human PON2 diminished not only ROS but also ER stress-
induced apoptosis in vascular cells [50]. PON2 is expressed in
several tissues with antioxidant properties. It is capable of
preventing cell-mediated oxidative modification of low density
lipoprotein and ER stress-induced apoptosis. [7,9,51]. PON2 is
not present in serum lipoprotein fractions but exists as an
intracellular protein found in almost every tissue, particularly at
the perinuclear region, ER and mitochondria. [7,50,52]. Natural
substrates remain unknown albeit PON2, as part of the innate
immune system, appears involved in the defense against infections
by the human pathogen Pseudomonas aeruginosa [52]. Several studies
demonstrated that PON2 protected macrophages, vascular and
other cells against oxidative stress, whereas its downregulation
reversed this effect [7,50,53].
PON2 has been shown to be overexpressed in several cancers
and it has been suggested that this may be due to the fact that
PON2 confers resistance to apoptosis as well as oxidative stress
[54]. It has been shown that during ER stress, high levels of PON2
lowered redox-triggered induction of pro-apoptotic CHOP
particularly via the JNK pathway, which prevented mitochondrial
cell death signaling [54]. Apart from CHOP, PON2 also
diminished intrinsic apoptosis as it prevented mitochondrial
superoxide formation, cardiolipin peroxidation, cytochrome c
release, and caspase activation. Oxidized lipids can also induce
proinflammatory genes, such as TNF-a and MCP-1, via NF-kB
activation [55]. Therefore one possibility is that less placental
PON2 would result in more oxidized lipids and more NF-kB
Figure 9. RQ values for mRNA measurements in inner, middle
and outer placental sites for labour compared with non-labour.
Comparison between zones was performed using Friedman analysis.
doi:10.1371/journal.pone.0096754.g009
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activation which would promote labour. Macrophages harvested
from PON2-/- mice are more susceptible to cellular oxidative
stress than wild-type macrophages [56]. PON2 also inhibits the
development of atherosclerosis in mice, via mechanisms involving
the reduction of oxidative stress [30,45,57]. One study investigated
the distribution of PON1 and 2 mRNA in 24 human tissues, using
gene expression panels. PON2 but not PON1 was identified in
placenta [58].
The mechanism by which PON2 modulates ROS production is
still unclear [59–62]. Lactones have been suggested to be the
natural substrates of PON2 and PON2 lactonase activity has been
shown to correlate with this enzyme’s biological antioxidant
properties.
Genetics studies
Studies have shown increased risk of coronary artery disease,
carotid atherosclerosis and stroke in patients with low paraoxonase
activity PON1 and 2 alleles [63]. Specific gene polymorphisms for
PON1 and PON2 have been reported in children born pre-term.
[63]. There is a lack of data in this new field. However term labour
results from a physiological reduction in the influence of endocrine
signals and other factors that act to inhibit myometrial contrac-
tility, in conjunction with the activation of pro-inflammatory
biochemical pathways that precede myometrial activation and
contraction. Premature activation of inflammatory mediators is a
major feature of the pathophysiology of preterm labour and in
particularly very preterm labour where it is often induced by
infection [3]. Whether PON2 may be involved in pre-term labour
is worthy of investigation.
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